GA 6: The Blood Glucose-lowering Effect of Glucose-dependent Insulinotropic Polypeptide

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 29, 2019

Primary Completion Date

February 28, 2020

Study Completion Date

February 28, 2020

Conditions
Type2 Diabetes
Interventions
OTHER

Placebo

Saline infusion

OTHER

GIP receptor antagonist

Used for infusion on study days

DRUG

DPP-4 inhibitor

Oral administration of DPP-4 inhibitor in active treatment period

OTHER

Placebo tablet

Oral administration of placebo tablet in placebo treatment period

Trial Locations (1)

2900

Center for Clinical Metabolic Research, Copenhagen

All Listed Sponsors
lead

University Hospital, Gentofte, Copenhagen

OTHER

NCT03845179 - GA 6: The Blood Glucose-lowering Effect of Glucose-dependent Insulinotropic Polypeptide | Biotech Hunter | Biotech Hunter